%, with changes in core asset items as below: Cash and cash equivalents was Baht 1,359 million, an increase Baht 394 million or 40. 8% due to trade accounts receivable and inventories decreased. Current
Financial Statements 2nd quarter 2020 2nd quarter 2019 Increase (decrease) Total cost and total expenses: The Group had a total cost and expenses of Baht 349.7 million, a reduction of Baht 94.2 million or
3,693.57 (1,258.59) (34.1) Profit before FX 532.44 2,175.99 (1,643.55) (75.5) 2,516.29 3,879.22 (1,362.93) (35.1) * excluding fuel cost Quarter 2 6-Month Increase (Decrease) % Increase (Decrease) % The
December 2019 Increase (Decrease) % Net Assets 6,213 5,885 328 5.57 Net Liabilities 2,433 2,076 357 17.20 Shareholders’ equity 3,780 3,809 (29) (0.76) Assets As at December 31, 2020, the Company and its
and the three-month period ended March 31, 2020, respectively. The figures represent a period-on-period increase of 5.36% due mainly to an increasing in number of patients. Cost of hospital operations
Position As at 31 March 2020, total consolidated assets of the Company and its subsidiary increased by Baht 68.58 million or 2.33% compared with last year. An increase mainly caused by Right-of-use assets
and manage the inventory at the factory warehouses caused an expense of Baht 44.8 million, an increase of 2.3%. Allowance for the Decline in Value of Inventory Allowance for the decline in value of
Unit: Million Baht Projects Consolidated Revenue Project Revenue Increase (Decrease) % Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) 31th-Mar-20 31th-Mar-19
in domestic and international Registered Capital : Baht 1,000,000 with a par value of Baht 100 per share (the Joint Venture will increase capital to Baht 1,763 million within year 2020) Board’s
profit and net profit margin increased due to the increase in sales as well as an increase of gross profit margin. Financial position Unit: Million Baht As at As at Change September 30, 2020 September 30